Source: Circulation-cardiovascular quality and outcomes. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, DOENÇAS RARAS, SOBREVIDA, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORBICKI, Adam et al. Integrating data from randomized controlled trials and observational studies to assess survival in rare diseases insights from pulmonary arterial hypertension. Circulation-cardiovascular quality and outcomes, v. 12, n. 5, 2019Tradução . . Disponível em: https://doi.org/10.1161/CIRCOUTCOMES.118.005095. Acesso em: 04 nov. 2024.APA
Torbicki, A., Bacchi, M., Delcroix, M., Farber, H. W., Ghofrani, H. -A., Hennessy, B., et al. (2019). Integrating data from randomized controlled trials and observational studies to assess survival in rare diseases insights from pulmonary arterial hypertension. Circulation-cardiovascular quality and outcomes, 12( 5). doi:10.1161/CIRCOUTCOMES.118.005095NLM
Torbicki A, Bacchi M, Delcroix M, Farber HW, Ghofrani H-A, Hennessy B, Jansa P, Mehta S, Perchenet L, Souza R. Integrating data from randomized controlled trials and observational studies to assess survival in rare diseases insights from pulmonary arterial hypertension [Internet]. Circulation-cardiovascular quality and outcomes. 2019 ; 12( 5):[citado 2024 nov. 04 ] Available from: https://doi.org/10.1161/CIRCOUTCOMES.118.005095Vancouver
Torbicki A, Bacchi M, Delcroix M, Farber HW, Ghofrani H-A, Hennessy B, Jansa P, Mehta S, Perchenet L, Souza R. Integrating data from randomized controlled trials and observational studies to assess survival in rare diseases insights from pulmonary arterial hypertension [Internet]. Circulation-cardiovascular quality and outcomes. 2019 ; 12( 5):[citado 2024 nov. 04 ] Available from: https://doi.org/10.1161/CIRCOUTCOMES.118.005095
